SCHEDULE: BlackRock Discloses 8.9% Stake in Elanco Animal Health
Beneficial Ownership Report
BlackRock, Inc. has reported an 8.9% beneficial ownership stake in Elanco Animal Health Inc., holding over 44 million shares of common stock.
Summary
- BlackRock, Inc. beneficially owns 44,021,766 shares of Elanco Animal Health Inc. common stock.
- This ownership represents 8.9% of the total outstanding common stock of Elanco Animal Health Inc.
- BlackRock holds sole voting power over 42,268,742 shares and sole dispositive power over 44,021,766 shares.
- The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- BlackRock, Inc. is classified as a parent holding company (HC) for the purpose of this filing.
- BlackRock Fund Advisors is identified as an entity within BlackRock, Inc. that beneficially owns 5% or greater of Elanco's outstanding shares.
Sentiment
Score: 7
Explanation: The disclosure of a significant beneficial ownership stake by a major institutional investor like BlackRock is generally viewed as a positive indicator of confidence in the issuer's value and prospects.
Positives
- A significant 8.9% stake by a major institutional investor like BlackRock, Inc. can signal strong institutional confidence in Elanco Animal Health Inc.'s long-term prospects and management.
Negatives
- No direct negatives for Elanco Animal Health Inc. are disclosed in this beneficial ownership filing.
Risks
- No specific risks related to Elanco Animal Health Inc. are detailed in this beneficial ownership filing, as it primarily serves to disclose institutional ownership.
Future Outlook
This filing does not contain any forward-looking statements or guidance from Elanco Animal Health Inc. or BlackRock, Inc. regarding Elanco's future performance.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
Industry Context
BlackRock, Inc. is one of the world's largest asset managers, and its significant stake in Elanco Animal Health Inc. highlights institutional interest in the animal health sector. Elanco operates in a growing market driven by increasing pet ownership, advancements in veterinary medicine, and global food security needs.
Stakeholder Impact
- Shareholders of Elanco Animal Health Inc. may view BlackRock's substantial stake as a vote of confidence, potentially influencing market perception positively.
- The presence of a large institutional investor can sometimes lead to increased scrutiny on corporate governance and strategic decisions.
Key Dates
| Date | Description |
|---|---|
| 04/30/2023 | Date of previously revoked Power of Attorney for BlackRock, Inc. |
| 01/21/2025 | Execution date of the new Power of Attorney for BlackRock, Inc. |
| 09/30/2025 | Date of event which required the filing of this statement (as reported by BlackRock, Inc.) |
| 10/17/2025 | Signature date of the Schedule 13G filing by BlackRock, Inc. |
Keywords
Elanco Animal Health, BlackRock, Institutional Ownership, Common Stock, Schedule 13G, Beneficial Ownership, Animal Health
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.